dc.contributor.author | Saldaña, F. | |
dc.contributor.author | Steindorf, V. | |
dc.contributor.author | Srivastav, A.K. | |
dc.contributor.author | Stollenwerk, N. | |
dc.contributor.author | Aguiar, M. | |
dc.date | 2024-04-20 | en_US |
dc.date.accessioned | 2023-04-18T10:16:49Z | |
dc.date.available | 2023-04-18T10:16:49Z | |
dc.date.issued | 2023-04-15 | |
dc.identifier.uri | http://hdl.handle.net/20.500.11824/1587 | |
dc.description.abstract | The burden of sexually transmitted infections (STIs) poses a challenge due to its
large negative impact on sexual and reproductive health worldwide. Besides simple
prevention measures and available treatment efforts, prophylactic vaccination is a
powerful tool for controlling some viral STIs and their associated diseases. Here, we
investigate how prophylactic vaccines are best distributed to prevent and control STIs.
We consider sex-specific differences in susceptibility to infection, as well as disease
severity outcomes. Different vaccination strategies are compared assuming distinct
budget constraints that mimic a scarce vaccine stockpile. Vaccination strategies are
obtained as solutions to an optimal control problem subject to a two-sex Kermack–
McKendrick-type model, where the control variables are the daily vaccination rates
for females and males. One important aspect of our approach relies on conceptualizing
a limited but specific vaccine stockpile via an isoperimetric constraint. We solve the
optimal control problem via Pontryagin’sMaximum Principle and obtain a numerical
approximation for the solution using a modified version of the forward–backward
sweep method that handles the isoperimetric budget constraint in our formulation. The
results suggest that for a limited vaccine supply (20%–30%vaccination coverage), onesex
vaccination, prioritizing females, appears to be more beneficial than the inclusion
of both sexes into the vaccination program.Whereas, if the vaccine supply is relatively
large (enough to reach at least 40% coverage), vaccinating both sexes, with a slightly
higher rate for females, is optimal and provides an effective and faster approach to
reducing the prevalence of the infection. | en_US |
dc.format | application/pdf | en_US |
dc.language.iso | eng | en_US |
dc.rights | Reconocimiento-NoComercial-CompartirIgual 3.0 España | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/es/ | en_US |
dc.subject | Epidemiology, R0, HPV, Modeling | en_US |
dc.title | Optimal vaccine allocation for the control of sexually transmitted infections | en_US |
dc.type | info:eu-repo/semantics/article | en_US |
dc.identifier.doi | https://doi.org/10.1007/s00285-023-01910-y | en_US |
dc.relation.publisherversion | https://link.springer.com/article/10.1007/s00285-023-01910-y | en_US |
dc.relation.projectID | info:eu-repo/grantAgreement/Gobierno Vasco/BMTF | en_US |
dc.rights.accessRights | info:eu-repo/semantics/embargoedAccess | en_US |
dc.type.hasVersion | info:eu-repo/semantics/acceptedVersion | en_US |
dc.journal.title | Journal of Mathematical Biology | en_US |
dc.volume.number | 86 | en_US |
dc.issue.number | 75 | en_US |